By
Tecnomaco
0
comment

The health of the Italian pharmaceutical industry

Despite difficulties in supplies and the rising cost of raw materials, the Italian pharmaceutical industry still grew in 2022. Production was up 10 percent, with a total value of 38 billion euros and a 44 percent increase in exports. Signs that confirm the excellence of the Italian pharmaceutical supply chain, first in Europe with results that far exceed the main…



By
Tecnomaco
0
comment

EU: anti-crisis strategies focus on innovation

Innovation is a competitive advantage for European companies, which is essential to go along with the ecological transition, revitalise the economy, and ensure the well-being of citizens. The EU's anti-crisis strategies aim to strengthen autonomy in key high-innovation sectors such as pharma, which employed 840,000 people in 2021 and recorded a production value of €300 billion. "As well as driving…



By
Tecnomaco
0
comment

Health and sustainability: the EU’s global strategy

Health and sustainability are closely related issues, involving environmental, economic and social aspects. Among the main challenges facing the Pharma and Healthcare sector today is undoubtedly the need to accelerate the green transition: a priority for institutional agendas, but also for new consumer groups, which are increasingly inclined to buy eco-friendly products. The EU's global strategy, in addition to reaffirming…